Scilex Ownership | Who Owns Scilex?
Scilex Ownership Summary
Scilex is owned by 38.65% institutional investors, 25.96% insiders, and 35.39% retail investors. Goalvest advisory is the largest institutional shareholder, holding 0% of SCLX shares. SPDR® S&P Biotech ETF is the top mutual fund, with 3.24% of its assets in Scilex shares.
SCLX Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Scilex | 38.65% | 25.96% | 35.39% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Drug Manufacturers - General Stocks | 45.98% | 1.80% | 52.22% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Goalvest advisory | - | - | - |
Modus advisors | - | - | - |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Goalvest advisory | - | - | - |
Modus advisors | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Modus advisors | - | - | -2.78K |
Goalvest advisory | - | - | -7.28K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Goalvest advisory | - | - | -7.28K |
Modus advisors | - | - | -2.78K |
Sold Out
Holder | Change |
---|---|
Modus advisors | -2.78K |
Goalvest advisory | -7.28K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 99 | 6.45% | 49,076,082 | 45.69% | 38 | 5.49% | 40 | 25.00% | 12 | -20.00% |
Sep 30, 2024 | 93 | 2.20% | 33,684,178 | -15.43% | 26 | 2.42% | 32 | 18.52% | 15 | -16.67% |
Jun 30, 2024 | 91 | -9.90% | 39,830,277 | 41.48% | 33 | 4.39% | 27 | -42.55% | 18 | 80.00% |
Mar 31, 2024 | 101 | 9.78% | 28,151,703 | 8.49% | 27 | 6.93% | 47 | 38.24% | 10 | -16.67% |
Dec 31, 2023 | 92 | 9.52% | 25,949,669 | -10.07% | 19 | 4.67% | 34 | 13.33% | 12 | - |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
SPDR® S&P Biotech ETF | 5.94M | 3.24% | - |
Vanguard Total Stock Mkt Idx Inv | 3.71M | 2.03% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 2.09M | 1.14% | - |
iShares Russell 2000 ETF | 1.43M | 0.78% | - |
Direxion Daily S&P Biotech Bull 3X ETF | 620.13K | 0.34% | - |
iShares Russell 2000 Value ETF | 576.36K | 0.31% | - |
JPM Thematics Genetic Thrps C2 Acc USD | 397.32K | 0.30% | - |
Fidelity Small Cap Index | 528.04K | 0.29% | - |
Fidelity Extended Market Index | 524.17K | 0.29% | -3.34K |
BlackRock Extended Equity Market K | 375.77K | 0.28% | -160.00 |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Dec 18, 2024 | SHAH JAISIM | See Remarks | Buy | $13.80K |
Oct 31, 2024 | Ji Henry | Executive Chairperson | Buy | $8.35K |
Oct 29, 2024 | SHAH JAISIM | See Remarks | Buy | $31.67K |
Oct 18, 2024 | Followwill Dorman | - | Buy | $990.00 |
Oct 18, 2024 | Chun Jay | - | Buy | $4.75K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | - |
2024 Q4 | 10 | - |
2024 Q3 | - | - |
2024 Q2 | 5 | - |
2024 Q1 | - | - |
SCLX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools